CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 
 

ACRS's Net Income Growth by Quarter and Year

Aclaris Therapeutics Inc 's Net Income results by quarter and year




ACRS Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -22.80 -13.17 -18.59
III Quarter September -19.95 -21.15 -10.66 -55.32
II Quarter June -20.53 -18.16 -11.60 -49.88
I Quarter March -18.79 -28.75 -15.59 -37.57
FY   -59.27 -90.86 -51.02 -161.36



ACRS Net Income third quarter 2022 Y/Y Growth Comment
Aclaris Therapeutics Inc in the third quarter 2022 recorded net loss of $ -19.95 millions.

According to the results reported in the third quarter 2022, Aclaris Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Aclaris Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




ACRS Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Aclaris Therapeutics Inc 's third quarter 2022 Net Income $ -19.95 millions ACRS's Income Statement
Aclaris Therapeutics Inc 's third quarter 2021 Net Income $ -21.15 millions Quarterly ACRS's Income Statement
New: More ACRS's historic Net Income Growth >>


ACRS Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Aclaris Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACRS's III. Quarter Q/Q Net Income Comment
Even if Aclaris Therapeutics Inc in the III. Quarter 2022 showed net loss of $ -19.95 millions, it should be said, that those numbers show recovery compare to the -20.53 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Aclaris Therapeutics Inc achieved highest sequential Net Income growth. While Aclaris Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACRS's III. Quarter Q/Q Net Income Comment
Although Aclaris Therapeutics Inc in the III. Quarter 2022 revealed net loss of $ -19.95 millions, some analyst point out, that those numbers are slight up side relative to the -20.53 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Aclaris Therapeutics Inc achieved highest sequential Net Income growth. While Aclaris Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Aclaris Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -82.08 $ -83.27 $ -80.90 $ -90.87 $ -81.23
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Aclaris Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -82 millions in the Sep 30 2022 period.

Aclaris Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Aclaris Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -82 millions in the Sep 30 2022 period.

Aclaris Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ACRS's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ACRS's Competitors
Net Income Growth for Aclaris Therapeutics Inc 's Suppliers
Net Income Growth for ACRS's Customers

You may also want to know
ACRS's Annual Growth Rates ACRS's Profitability Ratios ACRS's Asset Turnover Ratio ACRS's Dividend Growth
ACRS's Roe ACRS's Valuation Ratios ACRS's Financial Strength Ratios ACRS's Dividend Payout Ratio
ACRS's Roa ACRS's Inventory Turnover Ratio ACRS's Growth Rates ACRS's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Pediatrix Medical Group Inc -0.19%$ -0.195 millions
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc -4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Te Connectivity Ltd -10.83%$ -10.831 millions
Semler Scientific inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Lemaitre Vascular Inc-16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Molecular Templates Inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Khosla Ventures Acquisition Co -22.51%$ -22.507 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Reynolds Consumer Products Inc -27.27%$ -27.273 millions
Taitron Components Incorporated-28.61%$ -28.614 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PS's Profile

Stock Price

PS's Financials

Business Description

Fundamentals

Charts & Quotes

PS's News

Suppliers

PS's Competitors

Customers & Markets

Economic Indicators

PS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071